Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Lymphomatoid Papulosis

imatinib mesylate has been researched along with Lymphomatoid Papulosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Alberti, S; Bellani, V; Bucelli, C; Cattaneo, D; Croci, GA; Iurlo, A; Maronese, CA1
Botella-Estrada, R; de Unamuno-Bustos, B; Navarro-Mira, MÁ; Torres-Navarro, I1
Espinet, B; Gallardo, F; García-Martínez, P; Hernandez-Muñoz, M; Llistosella, E; Pujol, RM; Rodríguez-Rivera, M; Sitjas, D1
Koury, MJ; Murray, JJ; Newman, JH1
Georgakis, GV; Medeiros, LJ; Oyarzo, M; Rassidakis, GZ; Younes, A1
Cowen, EW; Klion, AD; McBurney, E; McPherson, T1

Other Studies

6 other study(ies) available for imatinib mesylate and Lymphomatoid Papulosis

ArticleYear
Lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement: Successful imatinib treatment in two cases.
    The Journal of dermatology, 2023, Volume: 50, Issue:10

    Topics: Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Lymphomatoid Papulosis; Male; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Receptor, Platelet-Derived Growth Factor alpha; Transcription Factors

2023
Successful treatment with imatinib of lymphomatoid papulosis associated with myeloproliferative hypereosinophilic syndrome with PDGFRA rearrangement.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020, Volume: 18, Issue:4

    Topics: Antineoplastic Agents; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukemia; Lymphomatoid Papulosis; Male; Middle Aged; Protein Kinase Inhibitors; Skin Neoplasms; Treatment Outcome

2020
Imatinib Treatment of Lymphomatoid Papulosis Associated with Myeloproliferative Hypereosinophilic Syndrome Presenting the FIP1L1-PDGFRA Fusion Gene.
    Acta dermato-venereologica, 2017, Jul-06, Volume: 97, Issue:7

    Topics: Adult; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Gene Fusion; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphomatoid Papulosis; Male; mRNA Cleavage and Polyadenylation Factors; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Receptor, Platelet-Derived Growth Factor alpha; Skin Neoplasms; Treatment Outcome

2017
Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib.
    The American journal of medicine, 2003, Volume: 115, Issue:7

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Drug Therapy, Combination; Female; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Interleukin-5; Lymphomatoid Papulosis; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines

2003
Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2004, Volume: 17, Issue:8

    Topics: Antineoplastic Agents; Benzamides; Cell Division; Cell Line, Tumor; Flow Cytometry; Hodgkin Disease; Humans; Imatinib Mesylate; Immunohistochemistry; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Lymphomatoid Papulosis; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm

2004
Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis.
    The British journal of dermatology, 2006, Volume: 155, Issue:4

    Topics: Adult; Benzamides; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Lymphomatoid Papulosis; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha

2006